CLASS ACTION DEADLINE: Brodsky & Smith, LLC Reminds Investors of Approaching Deadlines Related to the Following Companies: EXC, MMSI, BAX

BALA CYNWYD, PA / ACCESSWIRE / January 14, 2020 / Brodsky & Smith, LLC reminds investors of important approaching deadlines regarding class action lawsuits against the following companies for violations of federal securities laws. If you purchased any of the below-listed stocks during the referenced time periods and want to discuss your legal rights, please contact Marc Ackerman, Esquire or Jordan Schatz, Esquire at 877-534-2590. There is no cost or financial obligation to you.

EXELON CORORATION (NASDAQ:EXC)

Shares purchased between February 9, 2019 and November 1, 2019

Deadline: February 14, 2020

According to the complaint,throughout the Class Period, the defendants made false and/or misleading statements and/or failed to disclose that: (i) Exelon and/or its employees were engaged in unlawful lobbying activities; (ii) the foregoing increased the risk of a criminal investigation into Exelon; (iii) ComEd's revenues were in part the product of unlawful conduct and thus unsustainable; and (iv) as a result, Exelon's public statements were materially false and misleading at all relevant times.

Additional information can be found at http://www.brodskysmith.com/cases/exelon-corporation-nasdaq-exc/, or call 877-534-2590. No cost or obligation to you.

MERIT MEDICAL SYSTEMS, INC. (NASDAQ:MMSI)

Shares purchased between February 26, 2019 and October 30, 2019

Deadline: February 3, 2020

According to the complaint, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (a) the integrations of Cianna and Vascular Insights, including their products, salespeople, and R&D facilities, had caused operational disruptions and reduced sales and were months behind schedule; (b) sales of acquired company products had slowed substantially due to pre-acquisition pipeline fill, in particular for Vascular Insights' products which, as late as July 2019, had zero orders during fiscal year 2019; and (c) in light of the foregoing, the Company's reported financial guidance for fiscal 2019 and 2020 was made without a reasonable basis.

Additional information can be found at http://www.brodskysmith.com/?post_type=cases&p=13407&preview=true, or call 877-534-2590. No cost or obligation to you.

BAXTER INTERNATIONAL (NYSE:BAX)

Shares purchased between February 21, 2019 and October 23, 2019

Deadline: January 24, 2020

According to the complaint, throughout the Class Period, defendants misrepresented and/or failed to disclose that: (1) certain intra-Company transactions, undertaken for the purpose of generating foreign exchange gains and losses, used foreign exchange rate conventions that were not in accordance with GAAP and enabled intra-Company transactions to be undertaken after the related exchange rates were already known; (2) Baxter lacked effective internal control over financial reporting; (3) as a result, Baxter's financial statements were misstated and would likely require correction or amendment; (4) due to Baxter's internal investigation, it would not be able to file its quarterly report for the period ending September 30, 2019, with the SEC on a Form 10-Q in a timely manner; and (5) as a result of the foregoing, defendants' statements about Baxter's business and operations lacked a reasonable basis.

Additional information can be found at http://www.brodskysmith.com/cases/baxter-international-nyse-bax/, or call 877-534-2590. No cost or obligation to you.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

ReleaseID: 572928